BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 14752867)

  • 1. Association of cytogenetic abnormalities with detection of BCR-ABL fusion transcripts in children with T-lineage lymphoproliferative diseases (T-ALL and T-NHL).
    Lo Nigro L; Sainati L; Mirabile E; Lanciotti M; Poli A; Leszl A; Basso G
    Pediatr Blood Cancer; 2004 Mar; 42(3):278-80. PubMed ID: 14752867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additional chromosomal abnormalities and variability of BCR breakpoints in Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia in Taiwan.
    Ko BS; Tang JL; Lee FY; Liu MC; Tsai W; Chen YC; Wang CH; Sheng MC; Lin DT; Lin KH; Tien HF
    Am J Hematol; 2002 Dec; 71(4):291-9. PubMed ID: 12447959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular diagnosis and clinical relevance of t(9;22), t(4;11) and t(1 ;19) chromosome abnormalities in a consecutive group of 141 adult patients with acute lymphoblastic leukemia.
    Rambaldi A; Attuati V; Bassan R; Neonato MG; Viero P; Battista R; Di Bona E; Rossi G; Pogliani E; Ruggeri M; Amaru R; Rivolta A; Giudici G; Biondi A; Barbui T
    Leuk Lymphoma; 1996 May; 21(5-6):457-66. PubMed ID: 9172811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cytogenetic and prognostic analysis in adult patients with Philadelphia chromosome-positive and bcr-abl positive acute lymphoblastic leukaemia].
    Li YN; Zou DH; Gu M; Zhao YZ; Qi JY; Mi YC; Wang JX; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2009 May; 30(5):298-302. PubMed ID: 19799123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular measurement of minimal residual disease in Philadelphia-positive acute lymphoblastic leukaemia.
    Radich JP
    Best Pract Res Clin Haematol; 2002 Mar; 15(1):91-103. PubMed ID: 11987918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of residual disease in Philadelphia-positive acute lymphoblastic leukemia: comparison of blood and bone marrow.
    van Rhee F; Marks DI; Lin F; Szydlo RM; Hochhaus A; Treleaven J; Delord C; Cross NC; Goldman JM
    Leukemia; 1995 Feb; 9(2):329-35. PubMed ID: 7869772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous expression of RBTN-2 and BCR-ABL oncogenes in a T-ALL with a t(11;14)(p13;q11) and a late-appearing Philadelphia chromosome.
    Fizzotti M; Chen EY; Link MP; Carroll AJ; Foroni L; Rabbitts TH; Crist WM; Clark SS
    Leukemia; 1994 Jul; 8(7):1124-30. PubMed ID: 8035604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lineage involvement by BCR/ABL in Ph+ lymphoblastic leukemias: chronic myelogenous leukemia presenting in lymphoid blast vs Ph+ acute lymphoblastic leukemia.
    Anastasi J; Feng J; Dickstein JI; Le Beau MM; Rubin CM; Larson RA; Rowley JD; Vardiman JW
    Leukemia; 1996 May; 10(5):795-802. PubMed ID: 8656674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eradication of residual bcr-abl-positive clones by inducing graft-versus-host disease after allogeneic stem cell transplantation in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Matsue K; Tabayashi T; Yamada K; Takeuchi M
    Bone Marrow Transplant; 2002 Jan; 29(1):63-6. PubMed ID: 11840146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. bcr-abl rearrangement in adult T-lineage acute lymphoblastic leukemia.
    Fabbiano F; Santoro A; Felice R; Catania P; Cannella S; Majolino I
    Haematologica; 1998 Sep; 83(9):856-7. PubMed ID: 9825585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of minimal residual disease in Ph+/bcr-abl+ acute lymphoblast leukemia by cytogenetic analysis, nested-PCR and flow cytometry].
    Xue F; Dong ZR; Zhang B; Gao LX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Aug; 11(4):372-5. PubMed ID: 12962565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymerase chain reaction analysis of BCR-ABL sequences in adult Philadelphia chromosome-negative acute lymphoblastic leukemia patients.
    Janssen JW; Fonatsch C; Ludwig WD; Rieder H; Maurer J; Bartram CR
    Leukemia; 1992 May; 6(5):463-4. PubMed ID: 1593911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and phenotypic spectrum of de novo Philadelphia positive acute leukemia.
    Lim LC; Heng KK; Vellupillai M; Tan LT; Boey BC; Lau LC; How GF
    Int J Mol Med; 1999 Dec; 4(6):665-7. PubMed ID: 10567681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and phenotypic analysis of Philadelphia chromosome-positive bilineage leukemia: possibility of a lineage switch from T-lymphoid leukemic progenitor to myeloid cells.
    Monma F; Nishii K; Ezuki S; Miyazaki T; Yamamori S; Usui E; Sugimoto Y; Lorenzo V F; Katayama N; Shiku H
    Cancer Genet Cytogenet; 2006 Jan; 164(2):118-21. PubMed ID: 16434313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular detection of a late-appearing BCR-ABL gene in a child with T-cell acute lymphoblastic leukemia.
    Tchirkov A; Bons JM; Chassagne J; Schoepfer C; Kanold J; Briançon G; Giollant M; Malet P; Deméocq F
    Ann Hematol; 1998; 77(1-2):55-9. PubMed ID: 9760154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection and significance of bcr-abl mRNA transcripts and fusion proteins in Philadelphia-positive adult acute lymphoblastic leukemia.
    Tuszynski A; Dhut S; Young BD; Lister TA; Rohatiner AZ; Amess JA; Chaplin T; Dorey E; Gibbons B
    Leukemia; 1993 Oct; 7(10):1504-8. PubMed ID: 8412311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG).
    Wrzesień-Kuś A; Robak T; Pluta A; Zwolińska M; Wawrzyniak E; Wierzbowska A; Skotnicki A; Jakubas B; Hołowiecki J; Nowak K; Kuliczkowski K; Mazur G; Haus O; Dmoszyńska A; Adamczyk-Cioch M; Jedrzejczak WW; Paluszewska M; Konopka L; Pałynyczko G
    Ann Hematol; 2006 Jun; 85(6):366-73. PubMed ID: 16523310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of fusion transcript reveals a subgroup with distinct biological properties and predicts relapse in BCR/ABL-positive ALL: implications for residual disease monitoring.
    Zaliova M; Fronkova E; Krejcikova K; Muzikova K; Mejstrikova E; Stary J; Trka J; Zuna J
    Leukemia; 2009 May; 23(5):944-51. PubMed ID: 19158828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant reduction of the hybrid BCR/ABL transcripts after induction and consolidation therapy is a powerful predictor of treatment response in adult Philadelphia-positive acute lymphoblastic leukemia.
    Pane F; Cimino G; Izzo B; Camera A; Vitale A; Quintarelli C; Picardi M; Specchia G; Mancini M; Cuneo A; Mecucci C; Martinelli G; Saglio G; Rotoli B; Mandelli F; Salvatore F; Foà R;
    Leukemia; 2005 Apr; 19(4):628-35. PubMed ID: 15744351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiplex reverse transcription-polymerase chain reaction as diagnostic molecular screening of 4 common fusion chimeric genes in Taiwanese children with acute lymphoblastic leukemia.
    Yang YL; Lin SR; Chen JS; Hsiao CC; Lin KH; Sheen JM; Cheng CN; Wu KH; Lin SW; Yu SL; Chen HY; Lu MY; Chang HH; Yen CT; Lin JF; Su YH; Li YP; Lin CY; Jou ST; Lin DT
    J Pediatr Hematol Oncol; 2010 Nov; 32(8):e323-30. PubMed ID: 20930648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.